INNOSCIENCE (02577) plans to issue 13.584 million new H shares for a net fundraising of approximately HK$544 million.

date
22/07/2025
avatar
GMT Eight
Agilex Biolabs (02577) announced that on July 22, 2025 (before the trading hours of the Hong Kong Stock Exchange), the company entered into a...
INNOSCIENCE (02577) announced on July 22, 2025, the company has entered into a placing agreement with a placing agent to issue a total of 13.584 million new H shares to at least six placees at a placing price of HK$40.50 per H share, representing a discount of approximately 8.89% to the closing price of HK$44.45 per H share on July 21, 2025. Assuming all the placing shares are successfully placed, the company is expected to raise approximately HK$544 million in net proceeds. Around 50% of the funds will be used to support the upgrading and iteration of the group's products, expand the technological research and development of new product applications to enhance product competitiveness, and increase the penetration rate of gallium nitride products in the end-market. Approximately 25% of the funds will be used to repay existing interest-bearing bank liabilities, and approximately 25% will be used for supplementing working capital and general operational purposes.